Cargando…
Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a systemic disease with bidirectional relationships with cardiovascular disease (CVD). Non-alcoholic steatohepatitis (NASH) is a more severe subtype of NAFLD. Patients with NASH exhibit more intra and extrahepatic inflammation, procoagulant im...
Autores principales: | Ghoneim, Sara, Dhorepatil, Aneesh, Shah, Aun Raza, Ram, Ganesh, Ahmad, Subhan, Kim, Chang, Asaad, Imad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407919/ https://www.ncbi.nlm.nih.gov/pubmed/32821336 http://dx.doi.org/10.4254/wjh.v12.i7.378 |
Ejemplares similares
-
The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study()
por: Ghoneim, Sara, et al.
Publicado: (2020) -
The Risk of Cerebrovascular Accidents in Inflammatory Bowel Disease in the United States: A Population-Based National Study
por: Ghoneim, Sara, et al.
Publicado: (2020) -
Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population
por: Liu, Xiao-Lin, et al.
Publicado: (2016) -
Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort
por: Khoudari, George, et al.
Publicado: (2019) -
Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients
por: Takaya, Hiroaki, et al.
Publicado: (2019)